Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Oliver Brooks"'
Magnetic Zeolite: Synthesis and Copper Adsorption Followed by Magnetic Separation from Treated Water
Autor:
Sofi Buzukashvili, Weiqing Hu, Roberto Sommerville, Oliver Brooks, Ozan Kökkılıç, Neil A. Rowson, Philippe Ouzilleau, Kristian E. Waters
Publikováno v:
Crystals, Vol 13, Iss 9, p 1369 (2023)
Zeolites are widely used in diverse applications, including the removal of heavy metals from wastewater. However, separating fine-sized zeolite particles from treated water is often a challenge. In this work, a novel method utilizing a colloidal poly
Externí odkaz:
https://doaj.org/article/d12b9fa6537d4f9480fae1690c3de411
Publikováno v:
January 2023. :36-41
The accepted detrimental effects of climate change and the anticipated increased frequency of cascading disasters means there is a pressing requirement to equip search and rescue teams with the capability to perform effective and complex risk assessm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3058bb5b539823d623fbfd6f5483d824
https://doi.org/10.47389/38.1.36
https://doi.org/10.47389/38.1.36
Autor:
Katherine E. Fleming-Dutra, Megan Wallace, Danielle L. Moulia, Evelyn Twentyman, Lauren E. Roper, Elisha Hall, Ruth Link-Gelles, Monica Godfrey, Kate R. Woodworth, Tara C. Anderson, Amy B. Rubis, Edwin Shanley, Jefferson M. Jones, Rebecca L. Morgan, Oliver Brooks, H. Keipp Talbot, Grace M. Lee, Beth P. Bell, Matthew Daley, Sarah Meyer, Sara E. Oliver
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:859-868
On June 17, 2022, the Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) amendments for the mRNA-1273 (Moderna) COVID-19 vaccine for use in children aged 6 months-5 years, administered as 2 doses (25 µg [0.25 mL] each), 4 we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72b5ed8afaf26923ccfa80ea4023a1af
https://doi.org/10.15585/mmwr.mm7126e2
https://doi.org/10.15585/mmwr.mm7126e2
Publikováno v:
Journal of Contingencies and Crisis Management.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e00e63e945e8db605816378441aae8c
https://doi.org/10.1111/1468-5973.12442
https://doi.org/10.1111/1468-5973.12442
Autor:
Grace M. Lee, Jefferson M. Jones, Mary Chamberland, Rebecca L. Morgan, Danielle Moulia, Sarah Mbaeyi, Matthew F. Daley, Kathleen Dooling, Oliver Brooks, Sujan Reddy, Sara E. Oliver, Jennifer P Collins, Doug Campos-Outcalt, Beth P. Bell, Stephen C. Hadler, Kate R. Woodworth, H. Keipp Talbot
Publikováno v:
Morbidity and Mortality Weekly Report
The Pfizer-BioNTech COVID-19 (BNT162b2) vaccine is a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine encoding the prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19. On August 23, 2021, the Food and Drug Admini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4db6af18634817480ceb6b802ab3c92b
https://doi.org/10.15585/mmwr.mm7045e1
https://doi.org/10.15585/mmwr.mm7045e1
Autor:
Mary Chamberland, Camille Kotton, Matthew F. Daley, Beth P. Bell, Sujan Reddy, Sara E. Oliver, Grace M. Lee, Rebecca L. Morgan, Monica Godfrey, Megan J. Wallace, Sarah Mbaeyi, Neela D Goswami, H. Keipp Talbot, Kathleen Dooling, Danielle Moulia, Kristine M. Schmit, Heidi Moline, Oliver Brooks, Stephen C. Hadler, Jennifer P Collins, Jefferson M. Jones, Doug Campos-Outcalt
Publikováno v:
Morbidity and Mortality Weekly Report
Three COVID-19 vaccines are currently approved under a Biologics License Application (BLA) or authorized under an Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) and recommended for primary vaccination by the Advisory Comm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c12a57653a5c9705322a10ecadf50795
http://europepmc.org/articles/PMC8568093
http://europepmc.org/articles/PMC8568093
Autor:
Hannah G. Rosenblum, Megan Wallace, Monica Godfrey, Lauren E. Roper, Elisha Hall, Katherine E. Fleming-Dutra, Ruth Link-Gelles, Tamara Pilishvili, Jennifer Williams, Danielle L. Moulia, Oliver Brooks, H. Keipp Talbot, Grace M. Lee, Beth P. Bell, Matthew F. Daley, Sarah Meyer, Sara E. Oliver, Evelyn Twentyman
Publikováno v:
MMWR. Morbidity and mortality weekly report. 71(45)
Four COVID-19 vaccines are currently approved for primary series vaccination in the United States under a Biologics License Application or authorized under an emergency use authorization (EUA) by the Food and Drug Administration (FDA), and recommende
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d997ebd137d28ddfd94c8e7372ee5368
https://pubmed.ncbi.nlm.nih.gov/36355612
https://pubmed.ncbi.nlm.nih.gov/36355612
Autor:
Evelyn Twentyman, Megan Wallace, Lauren E. Roper, Tara C. Anderson, Amy B. Rubis, Katherine E. Fleming-Dutra, Elisha Hall, Joy Hsu, Hannah G. Rosenblum, Monica Godfrey, W. Roodly Archer, Danielle L. Moulia, Laura Daniel, Oliver Brooks, H. Keipp Talbot, Grace M. Lee, Beth P. Bell, Matthew Daley, Sarah Meyer, Sara E. Oliver
Publikováno v:
MMWR. Morbidity and mortality weekly report. 71(31)
The NVX-CoV2373 (Novavax) COVID-19 vaccine is a recombinant spike (rS) protein nanoparticle vaccine with Matrix-M adjuvant to protect against infection with SARS-CoV-2, the virus that causes COVID-19. On July 13, 2022, the Food and Drug Administratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7a922d2520ba57177c6e6f822fbfb0b
https://pubmed.ncbi.nlm.nih.gov/35925807
https://pubmed.ncbi.nlm.nih.gov/35925807
Autor:
Megan, Wallace, Danielle, Moulia, Amy E, Blain, Erin K, Ricketts, Faisal S, Minhaj, Ruth, Link-Gelles, Kathryn G, Curran, Stephen C, Hadler, Amimah, Asif, Monica, Godfrey, Elisha, Hall, Anthony, Fiore, Sarah, Meyer, John R, Su, Eric, Weintraub, Matthew E, Oster, Tom T, Shimabukuro, Doug, Campos-Outcalt, Rebecca L, Morgan, Beth P, Bell, Oliver, Brooks, H Keipp, Talbot, Grace M, Lee, Matthew F, Daley, Sara E, Oliver
Publikováno v:
MMWR. Morbidity and mortality weekly report. 71(11)
The mRNA-1273 (Moderna) COVID-19 vaccine is a lipid nanoparticle-encapsulated, nucleoside-modified mRNA vaccine encoding the stabilized prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19. During December 2020, the vaccine was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f47420a9fb3221924e90b19cff222c56
https://pubmed.ncbi.nlm.nih.gov/35298454
https://pubmed.ncbi.nlm.nih.gov/35298454
Autor:
Oliver Brooks
Publikováno v:
Journal of the National Medical Association
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26e4e2b9b032d8d25b0233290d25521f